Is Corneal Refractive Therapy or Paragon CRT FDA approved?
Paragon CRT is the first therapeutic lens design approved by the FDA for overnight contact lens Corneal Refractive Therapy for the temporary reduction of myopia. Paragon Vision Sciences, the manufacturer of Paragon CRT, received the final written approval on June 13, 2002. The issuance of this approval is the culmination of the most extensive clinical study to date to establish the safety and efficacy of contact lens corneal reshaping in overnight use.
Related Questions
- What do I do to see adequately in the period of time between when I start Corneal Refractive Therapy with Paragon CRT and when I achieve full treatment?
- Is Corneal Refractive Therapy or corneal therapy or corneal refractive therapy FDA approved?
- Is Corneal Refractive Therapy or Paragon CRT FDA approved?
